Zurcher Kantonalbank (Zurich Cantonalbank) Spero Therapeutics, Inc. Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

$32.8 Billion
Q3 2024

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 21, 2022	SELL	$7.87 - $15.15 $10,042 - $19,331	-1,276 Reduced 39.55%	1,950 $17,000
Q4 2021 Feb 01, 2022	SELL	$13.09 - $18.77 $4,280 - $6,137	-327 Reduced 9.2%	3,226 $52,000
Q3 2021 Nov 15, 2021	BUY	$13.03 - $19.51 $1,224 - $1,833	94 Added 2.72%	3,553 $65,000
Q2 2021 Jul 30, 2021	BUY	$12.22 - $15.79 $2,004 - $2,589	164 Added 4.98%	3,459 $48,000
Q1 2021 May 03, 2021	BUY	$13.23 - $21.48 $43,592 - $70,776	3,295 New	3,295 $49,000

Others Institutions Holding SPRO

# of Institutions

Shares Held

13.9M

Call Options Held

200

Put Options Held

200

Anson Funds Management LP Dallas, TX

3.75M
Shares

$3.56 Million
0.6% of portfolio
Vanguard Group Inc Valley Forge, PA

1.76M
Shares

$1.68 Million
0.0% of portfolio
Atlas Venture Associates Ix, LLC Boston, MA

1.35M
Shares

$1.29 Million
14.54% of portfolio
Acadian Asset Management LLC Boston, MA

1.07M
Shares

$1.02 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

975K
Shares

$925,920
0.0% of portfolio

View Full List

About Spero Therapeutics, Inc.

Ticker SPRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,067,500
Market Cap $33.3M
Description
Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to ...

More about SPRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Account